Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A double blind, randomised, placebo-controlled trial evaluating the efficacy and safety of nerandomilast over 26 weeks in patients with Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Diseases (SARD-ILD)
Kim, H. J. (PI)
BOEHRINGER-INGELHEIM PHARMACEUTICALS
4/1/25 → 12/31/26
Project: Research project
-
A Phase 2, Multi-part, Randomized, Open-label, Assessor-blinded, Active-controlled, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants With Severe Refractory Diffuse Cutaneous Systemic Sclerosi
Kim, H. J. (PI)
NOVARTIS PHARMACEUTICALS CORPORATION
4/1/25 → 12/31/32
Project: Research project
-
1305-0031: An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally inpatients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)(FIBRONEER???-ON)
Kim, H. J. (PI)
BOEHRINGER-INGELHEIM PHARMACEUTICALS
1/1/24 → 4/1/26
Project: Research project
-
Comparison of interstitial lung disease diagnoses in urban and rural areas among participants in the pulmonary fibrosis foundation patient registry
Dimmock, A. E. F., Furuya, Y., White, E., Freiheit, E., Bascom, R. & Kim, H. J., Feb 28 2025, In: Heliyon. 11, 4, e42667.Research output: Contribution to journal › Article › peer-review
Open Access -
Predictors of long-term survival in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Kim, H. J., Mar 9 2025, In: Lung. 203, 1, p. 40 1 p.Research output: Contribution to journal › Article › peer-review
-
Does the presence of incidental lung abnormalities on low-dose CT for lung cancer screening lead to additional testing?
Kim, H. J., 2024, In: CHEST Pulmonary.Research output: Contribution to journal › Article › peer-review
-
Does the Presence of Lung Incidental Findings on Low-Dose CT for Lung Cancer Screening Lead to Additional Testing?
Larson, J., Kim, H. J., Freese, R. & Begnaud, A., Dec 2024, In: CHEST Pulmonary. 2, 4, 100096.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study
Kim, J. S., Murray, S., Yow, E., Anstrom, K., Kim, H. J., Flaherty, K. R., Martinez, F. J. & Noth, I., Nov 27 2023, In: CHEST. 165, 5, p. 1163-1173Research output: Contribution to journal › Article › peer-review
12 Scopus citations